SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-027659
Filing Date
2023-08-11
Accepted
2023-08-10 18:56:25
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1207512
2 ex31-1.htm EX-31.1 19745
3 ex31-2.htm EX-31.2 19801
4 ex32-1.htm EX-32.1 8685
5 ex32-2.htm EX-32.2 8605
  Complete submission text file 0001493152-23-027659.txt   6162974

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ensc-20230630.xsd EX-101.SCH 42959
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ensc-20230630_cal.xml EX-101.CAL 47437
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ensc-20230630_def.xml EX-101.DEF 190425
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ensc-20230630_lab.xml EX-101.LAB 375570
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ensc-20230630_pre.xml EX-101.PRE 294390
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 980672
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38306 | Film No.: 231161078
SIC: 2834 Pharmaceutical Preparations